Fabry's disease epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Ghsanadgol (talk | contribs) No edit summary |
|||
| (19 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Fabry's disease}} | {{Fabry's disease}} | ||
{{CMG}} | {{CMG}} {{AE}} {{GhazalS}} | ||
==Overview== | ==Overview== | ||
[[Fabry's disease]] is a rare condition with a [[prevalence]] of approximately 6:100,000 to 0.8:100,000 in men. This disease mostly affects men and has no rational disparities. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
* | ===Prevalence=== | ||
*In 2021, the [[prevalence]] of [[Fabry's disease|Fabry's]] disease was estimated to be approximately 6:100,000 to 0.8:100,000 in men. | |||
*The [[prevalence]] of classic [[phenotype]] is estimated approximately 4.5:100,000 to 2.5:100,000 in men. | |||
*The [[prevalence]] of atypical [[phenotype]] is about 100:100,000 to 33:100,000 in men and 16:100,000 to 2.5:100,000 in females.<ref name="pmid28613767">{{cite journal| author=| title=StatPearls | journal= | year= 2022 | volume= | issue= | pages= | pmid=28613767 | doi= | pmc= | url= }}</ref> | |||
===Incidence=== | |||
*Incidence of [[Fabry's disease|Fabry's]] disease is commonly underestimated.<ref name="pmid28613767">{{cite journal| author=| title=StatPearls | journal= | year= 2022 | volume= | issue= | pages= | pmid=28613767 | doi= | pmc= | url= }}</ref> | |||
===Gender=== | |||
*Men are more commonly affected with [[Fabry's disease]] than females. The male to female ratio is approximately 2 to 1.<ref name="pmid28613767">{{cite journal| author=| title=StatPearls | journal= | year= 2022 | volume= | issue= | pages= | pmid=28613767 | doi= | pmc= | url= }}</ref> | |||
=== | ===Race=== | ||
The [[prevalence]] of Fabry disease | |||
*The [[prevalence]] of Fabry's disease does not vary by race.<ref name="pmid28613767">{{cite journal| author=| title=StatPearls | journal= | year= 2022 | volume= | issue= | pages= | pmid=28613767 | doi= | pmc= | url= }}</ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Needs english review]] | |||
Latest revision as of 10:28, 14 July 2022
|
Fabry's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fabry's disease epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Fabry's disease epidemiology and demographics |
|
Risk calculators and risk factors for Fabry's disease epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ghazal Sanadgol, M.D.[2]
Overview
Fabry's disease is a rare condition with a prevalence of approximately 6:100,000 to 0.8:100,000 in men. This disease mostly affects men and has no rational disparities.
Epidemiology and Demographics
Prevalence
- In 2021, the prevalence of Fabry's disease was estimated to be approximately 6:100,000 to 0.8:100,000 in men.
- The prevalence of classic phenotype is estimated approximately 4.5:100,000 to 2.5:100,000 in men.
- The prevalence of atypical phenotype is about 100:100,000 to 33:100,000 in men and 16:100,000 to 2.5:100,000 in females.[1]
Incidence
Gender
- Men are more commonly affected with Fabry's disease than females. The male to female ratio is approximately 2 to 1.[1]
Race
- The prevalence of Fabry's disease does not vary by race.[1]